Skylands Capital, LLC Exact Sciences Corp Transaction History

Skylands Capital, LLC

$660 Million
Q4 2024

A detailed history of Skylands Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Skylands Capital, LLC holds 11,800 shares of EXAS stock, worth $631,654. This represents 0.1% of its overall portfolio holdings.

Number of Shares

11,800

Previous 400 2850.0%

Holding current value

$631,654

Previous $27,000 2355.56%

% of portfolio

0.1%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$49.33 - $71.97 $562,362 - $820,458	11,400 Added 2850.0%	11,800 $663,000
Q3 2024 Nov 01, 2024	SELL	$42.43 - $70.83 $528,253 - $881,833	-12,450 Reduced 96.89%	400 $27,000
Q2 2024 Jul 26, 2024	BUY	$41.33 - $74.26 $510,425 - $917,111	12,350 Added 2470.0%	12,850 $542,000
Q1 2024 May 03, 2024	SELL	$56.27 - $73.77 $2,813 - $3,688	-50 Reduced 9.09%	500 $34,000
Q3 2019 Oct 29, 2019	SELL	$90.37 - $122.49 $445,975 - $604,488	-4,935 Reduced 89.97%	550 $50,000
Q2 2019 Jul 29, 2019	SELL	$89.51 - $118.04 $1.61 Million - $2.12 Million	-17,970 Reduced 76.61%	5,485 $647,000
Q1 2019 Apr 30, 2019	SELL	$61.98 - $96.5 $234,284 - $364,770	-3,780 Reduced 13.88%	23,455 $2.03 Million
Q4 2018 Feb 07, 2019	SELL	$56.04 - $82.66 $207,348 - $305,842	-3,700 Reduced 11.96%	27,235 $1.72 Million
Q3 2018 Oct 22, 2018	SELL	$48.29 - $80.6 $1.65 Million - $2.75 Million	-34,100 Reduced 52.43%	30,935 $2.44 Million
Q2 2018 Jul 24, 2018	SELL	$37.84 - $69.96 $163,279 - $301,877	-4,315 Reduced 6.22%	65,035 $3.89 Million
Q1 2018 Apr 19, 2018	SELL	$39.82 - $57.53 $526,221 - $760,258	-13,215 Reduced 16.01%	69,350 $2.8 Million
Q4 2017 Jan 16, 2018	SELL	$46.49 - $60.51 $7.15 Million - $9.3 Million	-153,735 Reduced 65.06%	82,565 $4.34 Million
Q3 2017 Oct 19, 2017	BUY	$37.05 - $47.12 $8.75 Million - $11.1 Million	236,300	236,300 $11.1 Million

Others Institutions Holding EXAS

# of Institutions

660

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.47B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skylands Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skylands Capital, LLC with notifications on news.

Account

Skylands Capital, LLC Exact Sciences Corp Transaction History